INTELLIGENCE IN ACTION

Now Trending: EPCS Among Physicians and Medicare Part D Patients

October 22, 2019

As we approach the one-year anniversary of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act, I am optimistic about the direction of a key provision outlined in the legislation, that is, the use of electronic prescribing of controlled substance (EPCS) among Medicare Part D providers. Congress passed the SUPPORT Act in October 2018 to address the opioid epidemic, and within the law the SUPPORT Act requires that all Medicare Part D covered controlled substance prescriptions must be transmitted electronically by 2021. Although utilization of EPCS among Medicare Part D prescribers is on the rise, there is still room for growth in order to implement the new law by 2021.

In an effort to help drive adoption of EPCS,  I recently worked with researchers at the Office of the National Coordinator for Health Information Technology (ONC) on a data brief, Electronic Prescribing of Controlled Substances among Medicare Part D Prescribers 2015-2016.

In a nutshell, we studied the landscape of Medicare Part D prescribers’ use of EPCS between 2015 and 2016 by prescriber specialty, prescriber state, and by Part D opioid claim volume.

According to the data brief, pain management specialists had the largest proportion of EPCS utilizers, among Medicare Part D Prescribers, that is, 21% of these specialists transmitted their controlled substance prescriptions, electronically.

Between 2015 and 2016 the proportion of all Medicare Part D prescribers who used EPCS increased from 4% to 11% and Medicare Part D opioid prescribers using EPCS more than doubled, from 5% in 2015 to 13% in 2016. While we still have a long way to go, we’re making progress. For reference, EPCS enablement among all prescribers (not just Medicate Part D) has climbed to more than 41% as of September 2019.

The work that went into this data brief —and the results it generated—also help us to understand which prescribers are using EPCS and the areas of the country where it’s being utilized. Additionally, it provides the analytical framework to anticipate continued growth in EPCS among Medicare Part D prescribers, and follow that trend to 2021 and beyond. It’s worth noting that our findings were consistent with the EPCS state rankings outlined in Surescripts’ 2016 National Progress Report, where New York State led the way in EPCS adoption and utilization, followed by North Dakota, and South Dakota; all states with a higher proportion of Medicare Part D prescribers.

The opioid crisis has devastated countless communities across the country, and this technology can impact patients, heal families and start to rebuild those communities. We must continue working together across the industry and with government in order to impact provider behavior in a way that helps fight the epidemic.

Read ONC’s blog post for more insight into the data report findings.

Related Articles

November 11, 2019

50 Days and Counting: Take These Necessary Steps to Meet EPCS Requirements

Fraud and abuse are prevalent in the world of prescription painkillers. In 2017, a total of 61,311 people died from drug overdoses – with an estimated 40% from prescription opioid medicine. This is 61,311 too many. Opioid diversion is a significant cause of opioid misuse, with between 3% and 9% of diverted drugs tied to fraud or forgery of paper prescriptions.

Read more...
July 30, 2019

Lessons Learned: How Connecticut Implemented an EPCS Requirement That Was Effective and Embraced by the Medical Community

Connecticut’s Electronic Prescribing of Controlled Substances (EPCS) requirement came into effect in January 2018. As Drug Control Director, I often serve as an advisor to state legislators who want to ensure the bills they draft are effective once they become law, so I was very active in the 2017 legislative session. While crafting this bill, we looked at how other states managed implementation of EPCS and worked closely with medical professionals to ensure that our legislation was thoughtful. We knew we had to consider the day-to-day operations of regulators and medical professionals, and ultimately what was best for patients.

Read more...
July 08, 2019

Medication History Can Help Prescribers Put the Federal Opioid Prescribing Guideline into Practice

The opioid crisis has prompted stakeholders along the healthcare continuum to act. In 2016, the Centers for Disease Control (CDC) issued their guideline on opioid prescribing for chronic pain. I recently spoke with my colleague, Dr. Carol Forster, an expert in pharmacotherapy and chronic pain management and a consultant to the Drug Enforcement Agency, to discuss how the guideline will help prescribers deliver effective pain management in an environment fraught with risk. Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX